ArticleCureus2026
Clinical, Microbiological, and Outcome Characteristics of Pediatric Patients With Candidemia at the Pediatric Hospital of the National Medical Center Siglo XXI From 2022 to 2025.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCandidemia is a major healthcare-associated infection in pediatric populations, driven by invasive medical interventions and shifts in fungal epidemiology toward non-albicans Candida species. Mortality remains high worldwide, particularly in infants and critically ill children. Updated regional data from tertiary-care centers are essential to guide prevention and treatment strategies.
methodsAn observational, retrospective, cross-sectional study was conducted at the Pediatric Hospital of the National Medical Center Siglo XXI (2022-2025). Patients aged 0-17 years with at least one positive blood culture for Candida spp. were included. Exclusion criteria comprised bacterial coinfection, palliative care, absence of antifungal treatment, incomplete clinical records, and diagnoses made at external institutions. Clinical characteristics, risk factors, species distribution, antifungal susceptibility, treatment, and outcomes were analyzed.
resultsA total of 99 patients were evaluated, of whom 42 met the inclusion criteria. Of these, 28 (66.7%) were male patients, and the most frequent age group was infants, with 20 patients. The main risk factors were central venous catheter use in 42 patients (100%), prior antibiotic use in 39 patients (92.9%), mechanical ventilation in 35 patients (83.3%), and ICU stay in 33 patients (73.8%). Non-albicans species predominated with 34 isolates (80.9%), with
conclusionCandidemia in this pediatric cohort was predominantly caused by non-albicans Candida species, particularly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.